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Humid indoor environments may be colonised by allergenic fi lamentous microfungi (moulds), Aspergillus 
spp., Penicillium spp., Cladosporium spp., and Alternaria spp. in particular. Mould-induced respiratory 
diseases are a worldwide problem. In the last two decades, mould allergens and glucans have been used 
as markers of indoor exposure to moulds. Recently, mould allergens Alt a 1 (Alternaria alternata) and 
Asp f 1 (Aspergillus fumigatus) have been analysed in various environments (residential and occupational) 
with enzyme-linked immunosorbent assays, which use monoclonal or polyclonal antibodies. Household 
Alt a 1 and Asp f 1 levels were usually under the limit of the method detection. By contrast, higher levels 
of mould allergens were found in environments with high levels of bioaerosols such as poultry farms and 
sawmills. Data on allergen Alt a 1 and Asp f 1 levels in agricultural settings may provide information on 
possible colonisation of respective moulds and point out to mould-related diseases in occupants.
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Humans continuously inhale spores and fragments 
of allergenic moulds. Exposure to fungal allergens in 
outdoor and indoor environments might result in 
respiratory diseases in sensitive individuals (1). 
However, indoor exposure to mould allergens has not 
received due attention. This article gives a brief review 
of the fi ndings of Alt a 1 (Alternaria alternata) and 
Asp f 1 (Aspergillus fumigatus) as markers of mould 




Generally, Cladosporium spp. and Alternaria spp. 
are the most common moulds outdoors worldwide 
(2-4). Fungal ecology is influenced seasonally, 
geographically, and by the diurnal cycle (2, 5). In 
Zagreb, Croatia, Alternaria spp. and Cladosporium 
spp. spores are detectable from May to November, 
peaking in the late summer (6). A similar seasonal 
pattern has been reported in other temperate European 
climates (7). On 17 days of August 2003, Zagreb air 
concentration of Alternaria spores exceeded the limit 
value of 100 spores per m3 , which is associated with 
increased risk of allergy (8). This concentration of 
airborne moulds was infl uenced by meteorological 
conditions (temperature, humidity, solar radiation, 
wind, and rainfall). In the United Kingdom, Alternaria-
related asthma has been reported in association with 
thunderstorms in the summer of 2002 (9). Alternaria 
spores can get dispersed over hundreds of miles from 
the source, especially in dry seasons. In addition, 
human activities, especially in agricultural settings 
can considerably contribute to the mould load in 
outdoor environments (10, 11).
Indoor environments
Healthy houses and buildings with low indoor 
humidity do not favour indoor fungal growth (10). 
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Generally, the composition of indoor airborne fungi 
in healthy, non-mouldy houses resembles the 
composition of outdoor fungi (Alternaria and 
Cladosporium) (2, 12, 13-15). Table 1 shows a marked 
difference between the distribution of moulds in 
healthy and sick/mouldy dwellings. It also shows 
currently thresholds for moulds in homes. In healthy 
indoor environments, indoor-to-outdoor mould ratio 
(I:O) is <1 (2, 10, 16). Shelton et al. (2) reported a 
median I:O in a US building of 0.16. In contrast, in 
sick buildings the I:O ratio was >1, which points to 
considerable indoor sources of moulds. In damp 
buildings, moulds can grow and sporulate on the 
surface of the building material and in settled dust 
(15). Aspergillus versicolor is one of the most common 
moulds in damp buildings in European countries, the 
United States, and Canada (17). Pei-Chih et al. (13) 
reported an extremely high I:O ratio of 9.6 for 
Aspergillus in a suburban area of Taiwan. In indoor 
environments heavily contaminated with fungi, mould 
concentrations are usually up to three orders of 
magnitude higher than in healthy houses (Table 1). 
The highest fungal load has been detected in mould-
contaminated houses in New Orleans after Hurricane 
Katrina (18, 19). Based on previous studies, moulds 
are suggested as bioindicators of indoor air quality 
(10).
Mould spores and fragments
The aerodynamic size of the spores is typical for 
the species. The conidia of the Aspergillus spp. and 
Penicillum spp. (mostly 2 μm to 5 μm in diameter) 
are relatively small compared to the spores of 
Alternaria spp. (10 μm to 40 μm in diameter) (1, 20). 
During sporulation, mould spores and hyphae are 
released into the air in a large number and inhaled 
(21). Generally, airborne mould spores with the 
aerodynamic diameter of >10 μm are deposited in the 
upper respiratory tract. They are associated with nasal 
and ocular symptoms (hay fever) (22, 23). On the other 
hand, particles in the range of 2 μm to 10 μm, 
especially those <5 μm, are respirable and can trigger 
allergic reaction. Laboratory-based studies have 
shown that moulds release into the environment large 
quantities of particles far smaller than spores (0.03 μm 
to 2 μm in diameter) (24-27). This fragmentation of 
spores is caused by various physical and biological 
processes (21-25, 28, 29). In two school buildings, the 
highest concentration of airborne fungal fragments 
was in the size range of 1.1 μm to 4.7 μm. This 
indicates that smaller particles are very common, 
especially in damp buildings as opposed to healthy 
ones (30). Similarly, Gorny et al. (24) and Reponen 
et al. (29) demonstrated considerably higher levels of 
mould fragments than of intact spores in mould-
contaminated buildings. Inhaled ultrafi ne particles 
(<1 μm) can penetrate deeply into the lung alveoli and 
make the respiratory symptoms and diseases even 
worse (28-30).
ALLERGENS OF A. FUMIGATUS AND
A. ALTERNATA
Most fungal allergens have been identifi ed from 
their conidia, hyphae, and small mycelial fragments 
(24, 31, 32). All these particles contribute to exposure 
and allergic sensitisation in humans. Fungal allergens 
have been investigated systematically only in A. 
fumigatus, A. alternata, and Cladosporium herbarum 
(22, 33). Among more than 100 genera of fungal 
aeroallergens, A. fumigatus produces more allergenic 
molecules than other moulds (31-34). Table 2 lists A. 
fumigatus allergens recognised by World Health 
Organization and International Union of Immunological 
Societies (WHO/IUIS) Allergen Nomenclature Sub-
Table 1 Mould aerosols in healthy, sick, and fl ooded buildings
Building I:Oa Dominant mould Total fungi / cfu m-3
Spores 
per m3 Mycotoxin Stachybotrys Ref.
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committee. Currently, the list refers to 23 molecules 
(35). Asp f 1 (ribotoxin) is the main allergen and a 
critical factor in provoking allergic response (type I 
hypersensitivity) and bronchopulmonary aspergillosis 
(36-40). Asp f 1 is a conserved protein, highly specifi c 
to A. fumigatus and not present in other members of 
the genus (35, 36, 41). Recently, Asp f 34 has also 
been identifi ed as a major allergen associated with 
sensitisation to Aspergillus (42). With the exception 
of Asp f 1 and Asp f 5 (metalloprotease), A. fumigatus 
allergens are homologous to the allergens of A. 
nidulans, A. oryzae, and other fungal species (35, 41). 
In addition, some allergens such as Asp f 11 and Asp 
f 27 (cyclophilins), and Asp f 28 and Asp f 29 
(thioredoxins) are homologous to human antigens 
(cross-reactive pan-allergens) (38). Allergens from 
other aspergilli has been less investigated. Beendorf 
et al. (43) identifi ed seven allergens in A. versicolor 
spores. Recently, Liang at al. (17) identifi ed two 
proteins (with molecular mass of 43 kDa and 41 kDa) 
in A. versicolor, which could be specifi c for this 
mould. A. niger and A. oryzae used in industrial 
fermentations have been recognised as important 
occupational allergens in baker’s asthma (33).
Table 3 shows A. alternata allergens. They include 
the following proteins: aldehyde dehydrogenase, heat 
shock protein, enolase, ribosomal protein P1 and P2, 
as well as other related uncharacterised proteins (33, 
45). Alt a 1 is the major allergen of A. alternata, as 
more than 80 % of patients allergic to Alternaria spp 
are sensitised to it (45, 46). Recent studies have found 
homologues of Alt a 1 in the phylogenetically related 
Stemphylium and Ulocladium species. This suggests 
that Alt a 1 may not be species-specifi c (47, 48). 
Several other A. alternata allergens have shown 
significant cross-reactivity with a closely related 
mould C. herbarum and with non-fungal species (47). 
Other worldwide-occurring moulds such as C. 
herbarum and Penicilium spp. are also important 
sources of allergens for mould-allergic patients (33). 
Cross-reactivity between the most common allergenic 
moulds has been presented elsewhere (47-51).
Several studies have shown that germination of 
Alternaria and Aspergillus spores plays a signifi cant 
role in allergen release in the environment, including 




Sample collection is an important step in the 
analysis of indoor moulds. However, optimal sampling 
methods and standard protocols for routine assessment 
of mould exposure have not yet been established (54, 
55). Generally, there are two techniques for 
Table 2 Allergens of A. fumigatus
Allergen Nature of allergen
Asp f 1 Ribotoxin, major allergen
Asp f 2 Fibrinogen binding protein, major allergen
Asp f 3 Peroxysomal membrane protein
Asp f 4 Unknown
Asp f 5 Metalloproteinase, protein degradation
Asp f 6 Mn-superoxide dismutase, pan-allergen
Asp f 7 Unknown




Asp f 10 Aspartic endopeptidase, protein degradation
Asp f 11 Cyclophilin, cross-reactive pan-allergen
Asp f 12 Heat-shock protein, hsp 90
Asp f 13 Alkaline serine protease
Asp f 15 Alkaline serine protease
Asp f 16 Putative glycosylhidrolase
Asp f 17 Galactomannoprotein
Asp f 18 Vacuolar serine protease
Asp f 22 Enolase
Asp f 23 L 3 ribosomal protein
Asp f 27 Cyclophilin, cross-reactive pan-allergen
Asp f 28 Thioredoxin, cross-reactive pan-allergen
Asp f 29 Thioredoxin, cross-reactive pan-allergen
Asp f 34
PhiA cell wall protein, protease, major 
allergen
Table 3 Allergens of A. alternata
Allergen Biological activity
Alt a 1 unknown, major allergen
Alt a 2 Aldehyde dehydrogenase, major allergen
Alt a 3 Heat shock 70 protein
Alt a 4 Protein disulfi de isomerase
Alt a 5 P2 ribosomal protein
Alt a 6 Enolase
Alt a 7 YCP4 protein
Alt a 8 Mannitol dehydrogenase
Alt a 10 Aldehyde dehydrogenase
Alt a 12 P1 ribosomal protein
GP70 Major allergen
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bioparticulates: air and surface sampling (56). Air 
sampling is suitable for determining spore count and 
viable mould parts (1, 54). Settling of bioaerosols 
depends on the diameter of a particle, and environmental 
and physical factors (15). Settled dust can be a 
reservoir of mould spores, their components 
(conidiophores, hyphae, fi ne fragments, allergens, 
glucans), and their metabolites (mycotoxins) 
accumulated over time (57, 58). While air sampling 
may be a good proxy for recent mould exposure 
associated with acute symptoms, dust sampling may 
be a good proxy for long-term exposures, especially 
in epidemiologic studies (14, 59). However, dust 
sampling does not give information about the potential 
of contaminants to aeorosolise (57).
Methods
Traditional methods (culture-based and microscopy) 
are the primary laboratory tools for mould detection 
and identifi cation (55). However, these methods have 
serious limitations. Cultivation-based methods do not 
identify dead or dormant mould fragments, which also 
may act as antigens (5). Furthermore, microscopic 
spore count does not identify smaller fungal fragments 
and hyphae. Germinated hyphae have higher allergenic 
activity that fungal conidia; therefore, hyphae 
significantly affect the air quality of mould-
contaminated buildings (24, 53, 57). Gorny et al. (24) 
suggested that spore count should be extended to 
fungal fragments (24).
In contrast to the traditional methods, molecular 
and immunological tests may detect all types of mould 
particles (60). Molecular methods (rDNA and qPCR) 
do not rely on the viability of organisms and can detect 
very small quantities of genetic material, which is 
especially valuable in assessing Aspergillus levels in 
hospitals (60-62). Pitkäranta et al. (62) suggested that 
a combination of traditional and molecular tests could 
give a more comprehensive picture of the fungal fl ora 
than any of the methods alone.
Several immunoassays (immunoblotting, Halogen 
immunoassay, and enzyme-linked immunosorbent 
assay - ELISA) have been used to identify mould 
allergens (31, 63). The halogen immunoassay is more 
common in experimental settings to demonstrate how 
aerosolised fungal fragments and hyphae act as 
aeroallergens, while the capture ELISA has found 
more practical application as a tool for detecting mould 
antigens in real-life (occupational or other) settings 
(64, 65). Commercial ELISAs are available for 
specific allergens Asp f 1 and Alt a1 and for A. 
versicolor and S. chartarum antigens. Due to cross-
reactive antigens among mould species, species-
specifi c tests are recommended for the detection of 
moulds in various environments (49, 65, 66). The 
advantages of immunoassays are the speed, analytical 
sensitivity, and the possibility to detect a relatively 
large number of samples in several hours.
ELISA for mould allergens
The mass fraction of Alt a 1 and Asp f 1 is usually 
measured in dust samples. The protocols for the mAb-
based Alt a 1 ELISA and mAb/pAb-based assay for 
Asp f 1 have been described elsewhere (32, 67-69). 
The limit of detection (LOD) for Asp f 1 is 3.6 ng g-1 
to 5.0 ng g-1 and for Alt a 1 0.12 μg g-1 (68-70). So far, 
no guideline or limit values for these major allergens 
in dust extracts have been suggested. Salo et al. (64) 
has proposed a cut-off point of 7 μg g-1 for overall 
Alternaria spp. antigens in household dust.
DETECTION OF ALT A 1 AND ASP F 1
House dust
Table 4 shows the levels of Alt a 1 and Asp f 1 in 
different environments. Neither allergen has been 
detected in settled dust in urban damp-free homes in 
Zagreb, Croatia (68, 69). Similar results were reported 
for Alt a 1 and Asp f 1 in several US studies (32, 70, 
71) and in Canada (72). Sporik et al. (32), detected 
Asp f 1 in only 5 % of households (32). These very 
low frequencies of Alt a 1 and Asp f 1 in household 
environments may be associated with a relatively low 
spore count typically found in healthy, non-mouldy 
houses (71).
Occupational environments
Unlike households, agricultural settings are usually 
associated with high exposure to moulds and allergic 
alveolitis (11). In our recent studies, we detected 
Alt a 1 and Asp f 1 in 100 % and 62 % of poultry farm 
dust samples, respectively (68, 69). Exposure to Alt a 1 
(median Alt a 10.37 μg g-1) in poultry farms was much 
higher than to Asp f 1 (median Asp f 117.9 ng g-1) 
(Table 4). Both exposures are relatively low, but we 
also observed wide ranges of mass fractions of both 
allergens. This suggests that reservoir dust in poultry 
farms may become a hazardous secondary source of 
occupational exposure to these allergens.
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There is little information on mould allergens in 
other occupational environments. Forestry and wood 
industry-related workplaces are characterised by high 
levels of bioaerosols containing moulds. Dillon et al. 
(56) detected Asp f 1 in air samples taken from a wood 
chipping facility and suggested it as a suitable marker 
of exposure to A. fumigatus (56). This study showed 
that Asp f 1ELISA was sensitive enough to detect 
airborne Asp f 1 in a sawmill. To my knowledge, 
fungal allergens have not been measured in other 
occupational settings.
OTHER INDICATORS OF INDOOR 
MOULDS
Mould constituents such as beta-1,3-glucan (57, 
73-75), ergosterol (74), and extracellular polysaccharides 
from Aspergillus and Penicillium (EPS-Asp/Pen) (75) 
have been used as general markers of fungal biomass. 
They have been used for exposure assessment to moulds 
in low-exposure environments and in damp buildings 
(73-76). In contrast to specifi c allergens, these indicators 
do not identify a specifi c mould.
HEALTH EFFECTS OF MOULDS
Generally, moulds can affect human health through 
allergic reactions, infections, and toxic responses 
(Table 5) (77, 78). Among them, sensitisation and 
allergic diseases are most commonly associated with 
inhalation of mould antigens. The major asthma-
related aeroallergen in children and adults worldwide 
is the genus Alternaria (79-81). Exposure to 
Cladosporium is associated with allergic respiratory 
symptoms in children (14, 82). The prevalence of 
mould allergy in atopic individuals is about 20 % to 
30 % and up to 6 % in the general population (83). A 
GA2LEN network survey by Heinzerling et al. (84) 
showed regional differences in sensitisation to mould 
allergens, which was higher in the UK and northern 
Europe than in the Mediterranean countries. Recent 
studies (24, 43, 85-87) have extensively investigated 
the role of indoor fungi such as Aspergillus and 
Penicillium in the pathogenesis of allergic diseases. 
A. fumigatus is the cause of 80 % of Aspergillus-
related diseases in humans (78). A. fumigatus-related 
allergies include rhinitis, allergic asthma, sinusitis, 
and allergic bronchopulmonary aspergillosis (ABPA) 
(Table 5). ABPA is a severe complication related to 
Table 4 Alt a 1 and Asp f 1 in settled dust 
Source Median Reference
Alt a 1 / μg g-1 Asp f 1 / ng g-1
Homes, offi ces <LOD <LOD 68-72
Poultry farms 0.37 17.9 68, 69
Sawmill <LOD >LODa 68
adata not presented
LOD - limit of detection
Table 5 Human diseases and symptoms caused by indoor moulds
Category Diseases Moulds Reference
Hypersensitivity






10, 14, 48, 77
11, 88




A. fumigatus 35, 78
Toxic 
Mycotoxicosis (toxins such as afl atoxins, 
trichothecenes, gliotoxin, ochratoxin) 
Stachybotrys,
Aspergillus 91-93
Nonspecifi c symptoms 
(sick building syndrome)
Nasal congestion, itchy and watering eyes, 
headache, fatigue, generalised malaise, airway 
infections, skin rash
various moulds 59, 85, 94-97
aAllergic bronchopulmonary aspergillosis
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A. fumigatus sensitisation and colonisation in the lung 
that affects patients with severe asthma (35, 39, 88, 
89). It is a frequent complication in cystic fi brosis 
patients (90). ABPA patients showed a marked increase 
in IgG and IgE antibodies against special A. fumigatus 
allergens (35). While recombinant allergens Asp f 4 
and Asp f 6 were used in serological diagnosis of 
ABPA (88), rAsp f 4 was effi cient in diagnosis of 
ABPA in patients with cystic fi brosis (90).
Fungal infection poses a particular risk for 
immunodeficient patients. Inhaled conidia of A. 
fumigatus may not be efficiently eliminated by 
immune mechanisms of these patients (38) and may 
cause life-threatening aggressive infections. Invasive 
aspergillosis is associated with the colonisation of the 
l ung  env i ronmen t  w i th  A.  fumiga tus  i n 
immunocompromised patients (leukaemia and bone 
marrow transplant patients, individuals infected by 
HIV) (35, 78). Hospitals should therefore take 
p a r t i c u l a r  c a r e  t o  c o n t r o l  e x p o s u r e  o f 
immunocompromised patients to this opportunistic 
mould.
OTHER HEATH EFFECTS OF INHALED 
INDOOR MOULDS
Indoor moulds produce mycotoxins that pose a 
health risk (10, 27, 91). The production of mycotoxins 
by building-associated moulds such as Stachybotrys 
spp., Aspergillus spp., and Penicillium spp. has been 
well documented, particularly in environments with 
high concentrations of airborne spores, including 
farms and compost-handling facilities (11). These 
mould species produce several mycotoxins such as 
afl atoxins, trichothecenes, gliotoxin, and ochratoxin 
(Table 5) (92). Similar to allergens, airborne 
trichothecene mycotoxins are associated with both 
spores and small (<2 μm) respirable mould particles 
(26, 27). Long-term exposure to living or dead 
particles containing fungal mycotoxins has been 
associated with immunsuppression in healthy people 
(11) and with haematotoxicity, infl ammation, and 
immunosuppression in laboratory animals (93). Jarvis 
and Miller (92) reported pulmonary mycotoxicosis in 
farmers exposed to very high quantities of mycotoxins 
at work.
Table 5 also shows the symptoms associated with 
poor indoor air quality and sick building syndrome 
(SBS). The aetiology of SBS is still not clear. Many 
studies have shown the association between dampness 
(94), fungal contamination (95), volatile organic 
compounds (11, 85), and building-related illnesses. 
There is evidence that Penicillium spp. and Aspergillus 
spp. may play a signifi cant role in SBS (96, 97). 
Furthermore, inhalation of beta-1,3-glucan from 
indoor moulds could be associated with non-allergic 
respiratory symptoms (98). However, Noss et al. (73) 
suggested that glucan exposure in early childhood can 
protect against the development of allergy (73). As 
potent immunological activators, beta-glucans have 
been recognised to possess a potential to act against 
several diseases (cancer, diabetes, infectious diseases) 
and to help patients to recover from chemotherapy 
and radiotherapy (99).
Further investigations are necessary to fi nd out the 
role of indoor moulds in aetiology of SBS and other 
diseases.
CONCLUSION
Monitoring of mould allergens in reservoir dust 
may be useful in assessing environmental contamination 
with moulds. However, due to high cross-reactivity 
among fungi, only several species-specifi c mould 
allergens (Alt a 1 and Asp f 1) have been identifi ed 
and used in environmental studies. In low-exposure 
environments determination of dust-borne Alt a 1 and 
Asp f 1 using ELISA seems to be limited. In 
bioaerosol-rich environments such as agricultural or 
wood-industry environments, however, determination 
of dust-borne Alt a 1 and Asp f 1 may be quite useful 
in assessing exposure to moulds. Further research 
should focus on determining mould allergens in air.
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Sažetak
IZLOŽENOST ALERGENIMA PLIJESNI U UNUTARNJEM OKOLIŠU
Vlažni, unutarnji prostori mogu biti kolonizirani alergogenim, fi lamentoznim mikrogljivicama (plijesni) 
uglavnom rodova Aspergillus, Penicillium, Cladosporium i Alternaria. Respiratorne bolesti uzrokovane 
plijesnima zdrastveni su problem diljem svijeta. U posljednja dva desetljeća, neki sastavni dijelovi plijesni 
kao alergeni i glukan rabe se kao pokazatelji izloženosti plijesni u unutarnjem okolišu. Nedavno su alergeni 
plijesni Alt a 1 (Alternaria alternata) i Asp f 1 (Aspergillus fumigatus) određivani u različitom okolišu 
(kućnom i profesionalnom) enzim-imunokemijskom metodom koja rabi monoklonska ili poliklonska 
antitijela. Razina Alt a 1 i Asp f 1 u kućnoj prašini ispod je granice detekcije. Nasuprot tomu, alergeni 
plijesni su određeni u okolišu s visokom razinom bioaerosola kao peradarnici i pilane. Razine alergena 
Alt a 1 i Asp f 1 u nekim poljoprivrednim objektima pružaju informaciju o mogućoj kolonizaciji plijesnima, 
što upućuje na moguće zdravstvene učinke kod zaposlenika.
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